AKOYA_logo_white_smallAKOYA_logo_white_smallAKOYA_logo_white_smallAKOYA_logo_white_small
  • Our Statement on COVID-19
  • Search
  • Login
  • Contact Us
  • Products
    • Solutions
      • Why Multiplex Imaging
      • Discovery to Translation
      • Biopharma Services
    • Products
      • CODEX® – Ultrahigh Multiplexed Imaging
      • PhenopticsTM – High-throughput Multiplexed Imaging
      • ProximaTM – Cloud Storage & Collaboration
  • Technology
    • Intro to CODEX
    • Intro to Phenoptics
  • Support
    • Hardware
    • Software
    • Reagents
    • FAQs
  • Resources
    • Akoya Academy
    • Literature
    • Videos
    • Webinars
    • Publications
    • Blog
  • Company
    • About Us
    • Leadership
    • Partners
    • Careers
    • News
    • Media Kit
    • Upcoming Events
  • Products
    • Codex
    • Phenoptics
    • Proxima
  • Solutions
    • Why Multiplex Imaging?
    • Discovery to Translation
    • Biopharma Services
  • Technology
    • Intro to CODEX
    • Intro to Phenoptics
  • Support
    • Hardware
    • Software
    • Reagents
    • FAQs
  • Resources
    • Akoya Academy
    • Literature
    • Videos
    • Webinars
    • Publications
    • Blog
  • Company
    • About Us
    • Leadership
    • Partners
    • Careers
    • News
    • Media Kit
    • Upcoming Events
  • Home
  • Akoya Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021

Akoya Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021

MENLO PARK, Calif. — January 11, 2021 — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced that Brian McKelligon, the company’s Chief Executive Officer, is scheduled to present at the J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021. Mr. McKelligon will provide a company overview of Akoya and its spatial phenotyping solutions.

About Akoya Biosciences
Akoya Biosciences, The Spatial Biology Company®, offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and other immune system or neurological disorders. The CODEX® system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics™ platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials. For more information, please visit akoyabio.com.

Media Contact:
Michelle Linn
Bioscribe, Inc.
774-696-3803
michelle@bioscribe.com

Products

  • CODEX
  • Phenoptics
  • Proxima

Solutions

  • Why Multiplex Imaging
  • Discovery to Translation
  • Biopharma Services

Support

  • Hardware
  • Software
  • Reagents
  • FAQs

Technology

  • Intro to CODEX
  • Intro to Phenoptics

Resources

  • Akoya Academy
  • Literature
  • Videos
  • Webinars
  • Publications
  • Blog

Company

  • About Us
  • Leadership
  • Partners
  • Careers
  • News
  • Media Kit
  • Upcoming Events



Akoya Biosciences is a registered trademark and The Spatial Biology Company is a trademark of Akoya Biosciences, Inc. A Delaware corporation.
Copyright © 2019 All Rights Reserved | Terms and Conditions | Privacy Policy
    • Our Statement on COVID-19
    • Search
    • Login
    • Contact Us